NIH/NIAID (R01 AI182082), “Vertical transmission, pregnancy outcomes, and treatment of Mpox virus infection in a translational pregnant macaque model.”  (2024-2028). Mohr, PI

NIH/NIAID (R01 AI153130), “Early neural predictors and neuropathogenesis of sensorimotor neurodevelopmental deficits in macaque infants exposed to Zika virus in utero” (2020-2025). Mohr & Ausderau, co-PI.

NIH/NIAID (R01 AI132519), “Pathways of vertical Zika virus transmission in nonhuman primate pregnancy” (2018-2024). Mohr, Co-Investigator

NIH/NIAID (P01 AI132132), “Zika virus pathophysiology during pregnancy” (2018-2023). Mohr, Co-Investigator


UW Office of the Vice Chancellor for Research & Graduate Education, “Travel grant – IDWeek 2019” (2019). Mohr, awardee

NIH/NCATS and University of Wisconsin Institute for Clinical and Translational Research (TL1 TR002375), “Defining maternal antibody responses in congenital Zika virus infection” (2018-2019). Mohr, Post-doctoral Trainee

Pediatric Infectious Diseases Society (Fellowship), “Development of a macaque congenital Zika syndrome model: Fetal Zika virus tissue distribution and pathology” (2017-2019). Mohr, Fellow

NIH/NIAID (T32 AI055397), “Microbes in health and disease” (2016-2017). Mohr, Post-Doctoral Trainee

NIH/NIAID (K08 AI139341), “Defining maternal and neonatal antibody responses in congenital Zika virus infection” (2019-2024). Mohr, PI